Efficacy of pazopanib with or without gemcitabine in patients with anthracycline- and/or ifosfamide-refractory soft tissue sarcoma: final results of the PAPAGEMO phase 2 randomized clinical trial - Schmoll, Hans-Joachim; Lindner, Lars H.; Reichardt, Peter; Heißner, Klaus; Kopp, Hans-Georg; Kessler, Torsten; Mayer-Steinacker, Regine; Rüssel, Jörn; Egerer, Gerlinde; Crysandt, Martina; Kasper, Bernd; Niederwieser, Dietger; et al. (JAMA oncology, 2021)
Gesehen am 01.07.2021